Inspire Medical Systems, Inc. · NYSE:INSP
Inspire Medical Systems — Stifel Healthcare Conference 2026
10 slides from Inspire Medical Systems's conference presentation, Nov 10, 2026
Slide 1: Inspire Medical Systems, Inc. Stifel Healthcare Conference 2026
Inspire Medical Systems, Inc. Stifel Healthcare Conference 2026 November 2026
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward- looking statements, including, without limitation, statements regarding estimated financi
Slide 3: Company overview
Company overview The first and only… >$10 BILLION Underpenetrated U.S. market >400 PUBLICATIONS Compelling body of evidence Innovative, closed-loop, ~1,300 EMPLOYEES neurostimulation Led by a proven management team technology >300 MILLION U.S. COVERED LIVES for Obstructive Sleep Established reimburs
Slide 4: Inspire Therapy is an Innovative and Proven Solution
Closed-loop, or Synchronized Stimulation, Inspire Therapy is is delivered when airway is most vulnerable to collapse (inspiratory phase) an Innovative and Proven Solution for Patients with 1 OSA Sensing with Inspire V is SUPERIOR to Inspire IV 2 Proprietary Closed-Loop Inspire V Sensing Algorithm to
Slide 5: Key catalysts and updates
Key catalysts and updates 1 2 3 Reimbursement Inspire V & Clinical Data Project Horizon Near term: Improved clarity 5th Gen system: Improved patient Created $30M of incremental regarding coding pathway, and outcomes and physician growth investment capacity: effective customer education experience Ex
Slide 6: Expanding Clinical Evidence Strengthens the Inspire Value Proposition
Expanding Clinical Evidence Strengthens the Inspire Value Proposition Recent studies expand the evidence supporting patient outcomes, cardiovascular health, and treatment pathway optimization Inspire V Performance Physiologic Disease Cardiovascular & Patient Identification & Impact Systemic Outcomes
Slide 7: 3Q26 Highlights
3Q26 Highlights1 Results Ahead of Expectations: 3.0% sequential revenue growth with $206.7M strength in U.S. business, coding and reimbursement disruption primary Revenue (7.9%) Y/Y, +3.0% Q/Q driver of Y/Y revenue decline of 7.9% Gross Margin Expansion: Gross margin expansion and disciplined spendi
Slide 8: Project Horizon Enables Incremental Growth Investment Capacity
Project Horizon Enables Incremental Growth Investment Capacity Optimizing Organizational Structure to Align Resources to Support Revenue Growth $30M Created incremental annualized growth investment capacity; prioritizing investments in patient flow Improving patient Expanding patient Support in navi
Slide 9: Summary
Summary Enhanced coding clarity in 2026 and 2027, new Category 1 CPT Code in 2028 Inspire V data shows improved patient outcomes and physician experience Recent studies expand the evidence supporting patient outcomes, cardiovascular health, and treatment pathway optimization Project Horizon creates
Slide 10: No mask. No hose. Just sleep.
No mask. No hose. ® Just sleep. 10 INSPIRE CONFIDENTIAL. Inspire is a public company and has an Insider Trading Policy. The content in this deck is not to be shared with anybody outside of Inspire Medical Systems, Inc. It is for internal review and discussion only www.inspiresleep.com
Inspire Medical Systems — Stifel Healthcare Conference 2026 on 6ix